SCHEMBL12154272

SCHEMBL12154272

Cc1ccc(-c2nc3c(s2)C(=O)OCC3)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 4/20 0.44
▸ RAB9A P51151 3/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ GAA P10253 1/20 0.39
▸ COMT P21964 1/20 0.39
▸ WNT3A P56704 1/20 0.39
▸ TNKS2 Q9H2K2 1/20 0.39
▸ PIK3CD O00329 1/20 0.37
▸ PIK3CA P42336 1/20 0.37
▸ PIK3CB P42338 1/20 0.37
▸ PIK3CG P48736 1/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ NPC1 O15118 2/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ LMNA P02545 3/20 0.35
▸ HTT P42858 1/20 0.35
▸ TRPM8 Q7Z2W7 1/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2074075 0.86 ALDH1A1 (0.42) ALOX5RAB9AKDM4EGAAWNT3A
SCHEMBL2076299 0.86 ALOX5 (0.44) ALOX5PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL2075217 0.85 ALOX5 (0.48) ALOX5RAB9AKDM4EGAAWNT3A
SCHEMBL2072998 0.82 TNKS2 (0.42) RAB9AKDM4EGAAWNT3ATNKS2
SCHEMBL2073156 0.77 KMT2A (0.43) RAB9AKDM4EKMT2AMEN1MAPT
SCHEMBL2073946 0.70 RAB9A (0.40) RAB9AKDM4EGAAPIK3CAMAPT
SCHEMBL8353356 0.65 COMT (0.47) ALOX5RAB9AKDM4EGAACOMT
SCHEMBL16806049 0.64 ALOX5 (0.71) ALOX5RAB9AKDM4EGAACOMT
SCHEMBL4309517 0.64 APP (0.46) RAB9AKDM4EGAAWNT3ATNKS2
SCHEMBL12965399 0.64 GRM5 (0.57) ALOX5RAB9APIK3CDPIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8049013-B2 5- [4-(azetidin-3-yloxy)-phenyl]-2-phenyl-5H-thiazolo[5,4-C] pyridin-4-one derivatives and their use as MCH receptor antagonists ELI LILLY AND COMPANY (US) 2011-11-01 — — US disclosed
US-20100069352-A1 5- [4-(AZETIDIN-3-YLOXY)-PHENYL]-2-PHENYL-5H-THIAZOLO[5,4-C] PYRIDIN-4-ONE DERIVATIVES AND THEIR USE AS MCH RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY 2010-03-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069352-A1 5- [4-(AZETIDIN-3-YLOXY)-PHENYL]-2-PHENYL-5H-THIAZOLO[5,4-C] PYRIDIN-4-ONE DERIVATIVES AND THEIR USE AS MCH RECEPTOR ANTAGONISTS MCHR1, MCHR2, HCRTR1 ALOX5 1853/4885RAB9A 3702/4885KDM4E 2614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback